GlassScriptPhysician profile
Morgan Hampton Randall
NPI 1326306523
$28,906.91
in general payments reported to CMS, 2019-2025
28 companies · $7,274 in 2025
The $7,274 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2021: $948 · 2022: $15K · 2023: $1,899 · 2024: $3,469 · 2025: $7,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,132 · Food and Beverage: $4,259 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Consulting Fee: $750 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,132.32 |
| Food and Beverage | $4,259.01 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Consulting Fee | $750.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,235.57 | 2021-2025 | Coroflow, Ultreon, Dragonfly Opstar |
| Medtronic, INC. | $10,810.98 | 2021-2025 | Ffrangio |
| Boston Scientific Corporation | $2,643.73 | 2019-2025 | General - Vascular Access, Avvigo Guidance System, Watchman Access System |
| Edwards Lifesciences Corporation | $1,649.62 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $339.42 | 2021-2025 | |
| Heartflow, INC. | $274.17 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $268.02 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $245.97 | 2022-2024 | Xarelto |
| Cardiovascular Systems INC. | $219.58 | 2019-2022 | |
| Pfizer INC. | $171.39 | 2024-2025 | |
| Philips North America LLC | $127.82 | 2022 | |
| Shockwave Medical, INC | $110.39 | 2022 | |
| Inari Medical, INC. | $99.49 | 2022 | |
| Amgen INC. | $89.36 | 2024-2025 | Repatha, Repatha |
| Cardiva Medical, INC. | $87.16 | 2024-2025 | Ensoetm, Savvywire |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $86.04 | 2019 | |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Inspire Medical Systems, INC. | $67.45 | 2024-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $62.00 | 2024-2025 | Opsumit, Uptravi, Opsynvi |
| Kiniksa Pharmaceuticals International, Plc | $38.44 | 2024 | Arcalyst |
| Genzyme Corporation | $33.03 | 2025 | |
| Novartis Pharmaceuticals Corporation | $32.98 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $29.23 | 2024 | Farxiga, Wainua |
| Kiniksa Pharmaceuticals, LTD. | $28.92 | 2023 | Arcalyst |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Vital Connect, INC | $20.00 | 2024 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $17.27 | 2024 | |
| Penumbra, INC. | $16.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Randall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.